Ayse Seda Yazgili

5PUBLICATIONS
64CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Wastewater treatment processesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
PA200 differentially regulates the proteasome and inhibits migration of NSCLC cells.

Ayse S Yazgili, Georgia A Giotopoulou, Sabine J Behrend

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Nov 24, 2022
TDP-43 condensates and lipid droplets regulate the reactivity of microglia and regeneration after traumatic brain injury.

Alessandro Zambusi, Klara Tereza Novoselc, Saskia Hutten

|Aug 26, 2022
The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease.

Ayse Seda Yazgili, Frédéric Ebstein, Silke Meiners

Pageof 1